The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults
Clinical trial NCT06224296 · UNKNOWN
Trial details
- NCT number
- NCT06224296
- Sponsor
- Shanghai Cell Therapy Group Co.,Ltd
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2024-12-31
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.